---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-028047"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:21:07.082819+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Vaxart granted Nasdaq extension; must complete reverse stock split by Oct 6, regain $1 bid price by Oct 17

## Summary
- Nasdaq Hearings Panel decision on Aug 27, 2025 grants continued listing with three conditions.
- Shareholder approval for reverse stock split required by Sep 5, 2025 special meeting.
- Reverse stock split must be completed by Oct 6, 2025; bid price compliance by Oct 17, 2025.
- Failure to obtain RSS approval will result in delisting per the Panel's decision.
- Vaxart engaged in stockholder outreach; management emphasizes RSS vote for Nasdaq future.

## SEC filing metadata
- accession: 0001437749-25-028047
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774925028047/0001437749-25-028047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774925028047/vxrt20250829_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-028047
- JSON: https://secwatch.observer/filing/0001437749-25-028047.json
- Plain text: https://secwatch.observer/filing/0001437749-25-028047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.